Fortwin 1ml Injection may cause excessive drowsiness and calmness with alcohol.
WEIGH RISKS VS BENEFITS
Fortwin 1ml Injection may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Fortwin 1ml Injection is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Do not drive unless you are feeling well. Fortwin 1ml Injection may cause sedation especially if taken with alcohol. This may impair your driving ability.
Fortwin 1ml Injection should be used with caution in patients with kidney disease. Dose adjustment of Fortwin 1ml Injection may be needed. Please consult your doctor.
Fortwin 1ml Injection should be used with caution in patients with liver disease. Dose adjustment of Fortwin 1ml Injection may be needed. Please consult your doctor.
If you miss a dose of Fortwin 1ml Injection, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
What were the side-effects while using Fortwin 1ml Injection?
How much was the improvement?
Please rate Fortwin 1ml Injection on price
What are you using Fortwin Injection for?
Survey Participants: 2
“The following are the results of on-going survey on 1mg.com for Fortwin 1ml Injection. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Fortwin is a narcotic opioid analgesic. It is a controlled substance
Q. Is pentazocine naloxone an opiate/ a narcotic?
Pentazocine naloxone contains 2 medications, pentazocine and naloxone. Pentazocine is a narcotic pain reliever (opiate-type). Naloxone counteracts the effect of opiate active ingredient in it and helps to prevent misuse of this product
Fortwin is absorbed from the gastro-intestinal tract; following administration by mouth, peak plasma concentrations are reached in 1-3 hours and the half-life is reported to be 2-3 hours, but it can be detected in urine from 1-3 days.